A 61-year-old man, without comorbidities, presented with a swelling on the neck associated with occasional pain. Neck ultrasound and computed tomography (CT) scan showed a 6x3 cm solid expansive mass to the soft tissue, on the left side of the neck, contiguous to the omolateral sternocleidomastoid muscle. This neoformation appeared non-homogeneous with irregular margins and extended from the plane passing through the hyoid bone to the left supraclavicular region with compression of the thyroid left lobe. Enlarged lymph nodes were present on both sides of the neck ([Figure 1](#f1-can-4-197){ref-type="fig"}).

The patient underwent surgical removal of the mass, with sternocleidomastoid muscle, internal jugular vein and lymph node dissection on the same side. On macroscopic examination, lymph nodes of different sizes to the lower pole and a muscle section to the higher pole were recognizable. On cut, a 5-cm grey, compact area, tending to friability, within the muscle, was examined.

Histology showed malignant neoplastic tissue invading the striated muscle. The tumour was formed of irregular nests and trabeculae of large polygonal cells with large nuclei, clumpy chromatin and prominent nucleoli and syncytial appearance. The nests of epithelial tumour cells were associated with a dense and accentuated lymphoid infiltrate ([Figure 2](#f2-can-4-197){ref-type="fig"}).

No keratinization could be seen in the tumour. Immunohistochemical examination revealed strong immunoreactivity for cytokeratins and epithelial membrane antigen (EMA) ([Figure 3](#f3-can-4-197){ref-type="fig"}), and negativity for vimentin, CD3 and CD20 ([Figure 4](#f4-can-4-197){ref-type="fig"}).

Conversely, the lymphocytic infiltrate was intensely stained with CD45 (leucocyte common antigen---LCA). Using subset markers, the large amounts of lymphocytes around the cords of carcinoma cells were CD3---positive T lymphocytes and CD20---positive B lymphocytes with a clear predominance of CD3---positive T lymphocytes, which consisted predominantly of CD8---positive cells \> CD4---positive cells. Some cells were also positive for lysozime and CD68 (macrophages).

*In situ* hybridization (RNA-ISH) and polymerase chain reaction (PCR) for detection of Epstein--Barr Virus (EBV) genome were negative in both epithelial and lymphocytic populations.

Lymph nodes were extensively necrotic and metastatic.

Morphological and immunohistochemical findings fulfilled the criteria for the diagnosis of lymphoepithelioma-like carcinoma (LELC).

A rhinofibrolaringoscopy and head-and-neck magnetic resonance imaging (MRI) did not show any residual tumour mass.

The patient was followed with CT-scan and MRI, and approximately four years after surgery is currently disease free.

Lymphoepithelial carcinoma, also known as lymphoepithelioma or nasopharyngeal carcinoma type III or Schmincke--Regaud tumour, is an undifferentiated nasopharyngeal carcinoma with lymphoid stroma and non-keratinizing squamous cells with distinctive clinical, epidemiological and etiological features \[[@b1-can-4-197]\].

Lymphoepithelioma-like carcinoma is a carcinoma arising outside of the nasopharynx, resembling lymphoepithelioma both histologically and immunophenotypically. It is a malignant epithelial tumour which is characterized by large and uniform cells with indistinct cytoplasmic borders, resulting in a syncytial growth pattern, round to vescicular and ovoid nuclei, and large central nucleoli \[[@b2-can-4-197]\]. Usually, an inflammatory infiltrate rich in mature lymphocytes (predominantly CD8+ and T-cells) and occasionally eosinophiles are also present, partially obscuring the neoplastic epithelial component \[[@b3-can-4-197]\].

Conventionally, LELCs have been classified as 'high grade' based on poor histological differentiation. LELC localizations have been described to the gastrointestinal tract \[[@b4-can-4-197]\], thymus, salivary glands \[[@b5-can-4-197]\], uterine cervix \[[@b6-can-4-197]\], skin \[[@b7-can-4-197]\], lung \[[@b2-can-4-197]\], oral cavity \[[@b8-can-4-197]\], breast \[[@b9-can-4-197]\], vagina \[[@b10-can-4-197]\], trachea, larynx and vocal cord \[[@b11-can-4-197]\], bladder, rarely to the renal pelvis, ureter \[[@b12-can-4-197]\], and only once to a scar \[[@b13-can-4-197]\].

While there is a strong etiopathological association between EBV and lymphoepithelioma, mostly in South-Eastern Asian people \[[@b14-can-4-197]\], a connection between LELC and EBV is more variable, and usually without any ethnic relevance. However, in cases of LELCs occurring in pharyngeal or foregut derivatives, the association is much stronger in Asians than in Caucasians \[[@b2-can-4-197]\]. Recently, EBV has consistently been observed in LELC of specified anatomic sites, such as lung, stomach, thymus and salivary gland \[[@b5-can-4-197]\].

Circulating serum EBV DNA could be used as a tumour marker in the clinical management of LELCs. In fact, in published results, patients with a pre-therapy serum EBV DNA \> 10.000 copies/ml had significantly worse survival \[[@b15-can-4-197]\]. Elevated levels six--eight weeks after therapy were strongly associated with both progression-free and overall survival \[[@b16-can-4-197]\].

At present, no validated therapeutic management exists for LELC. Surgery represents the best option in localized disease \[[@b5-can-4-197]\] sometimes followed with radiotherapy \[[@b17-can-4-197]\], whereas chemotherapy is not a conventional option.

Taxanes, platinum derivatives and 5-fluorouracil combined with folinic acid are active drugs \[[@b18-can-4-197]\].

The LELC has generally been considered to be highly radiosensitive, and post-operatory radiotherapy is indicated in cases of residual neoplastic tissue at the surgical margins, high-grade tumour, tumoural infiltration of adjacent organs or extensive locoregional diffusion \[[@b19-can-4-197], [@b5-can-4-197]\].

In locally advanced stages, a multimodality approach, including surgery, radiotherapy and chemotherapy, is advised \[[@b20-can-4-197]\].

Prognosis is linked to stage, grading, radical surgery and radiotherapy when the resection is not complete \[[@b5-can-4-197]\].

In the differential diagnosis of a connective tissue mass within the neck region an LELC should be considered as well as nasopharyngeal and metastatic squamous-cell lung carcinomas. Histologically, LELC cannot be distinguished from them, but clinical history and absence of a primary lesion to the nasopharynx or lung could drive the diagnosis.

Furthermore, a clear distinction between non-keratinizing carcinoma and large-cell lymphoma can be difficult. Accurate diagnosis is aided by a panel of immunohistochemical stains that uses epithelial markers and common leukocyte antigens.

In the present report, features favouring diagnosis of carcinoma include the presence of cohesive cell groups with poorly defined cell borders and an immunohistochemical profile of the neoplastic cells showing strong positivity for cytokeratin and EMA but negativity for LCA.

This presentation in a connective tissue appears to be very peculiar and unusual. To our knowledge, it could be the first reported case.

In our case, a possible primary site was not found, even though it cannot be absolutely excluded. However, a primary connective tissue LELC could be assumed, based on the branchial embryonic remnants origin, particularly from branchial cysts arisen from the second branchial arch \[[@b21-can-4-197]\]. In fact, these cysts, consisting of lymphoid aggregates that can have either squamous or respiratory-type epithelial lining, occur mostly along the front edge of the sternocleidomastoid muscle from the plane passing through the hyoid bone to the suprasternal notch \[[@b21-can-4-197], [@b22-can-4-197], [@b23-can-4-197]\].

These branchial cysts may develop into branchiogenic carcinomas starting from the cystic epithelial lining, which is considered a branchial remnant situated along the front edge of the sternocleidomastoid muscle, not associated with the development of any cancer within five years after diagnosis \[[@b24-can-4-197]\].

Finally, the long disease free survival, uncommon for a nasopharyngeal carcinoma, is another significant aspect suggesting a diagnosis of LELC.
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![Cytokeratin and EMA immunohistochemistry positive.](can-4-197f3){#f3-can-4-197}
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